These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20942266)

  • 1. Risk factors of recipient receiving living donor liver transplantation in the comprehensive era of indication and perioperative managements.
    Ishigami M; Katano Y; Hayashi K; Ito A; Hirooka Y; Onishi Y; Nakamura T; Kiuchi T; Goto H
    Nagoya J Med Sci; 2010 Aug; 72(3-4):119-27. PubMed ID: 20942266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of early recipient mortality after living donor liver transplantation in a tertiary care center in Egypt.
    Nafea MA; Alsebaey A; Abd El Aal Sultan A; Goda MH; Salman A; Rashed HS; Soliman A; Elshenoufy M; Abdelrahman M
    Ann Saudi Med; 2019; 39(5):337-344. PubMed ID: 31580715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult-to-adult living-donor liver transplantation: The experience of the Université catholique de Louvain.
    Iesari S; Inostroza Núñez ME; Rico Juri JM; Ciccarelli O; Bonaccorsi-Riani E; Coubeau L; Laterre PF; Goffette P; De Reyck C; Lengelé B; Gianello P; Lerut J
    Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):132-142. PubMed ID: 30850341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF; Yosephy A; Noble B; Aqel BA; Byrne TJ; Carey EJ; Douglas DD; Mulligan D; Moss A; de Petris G; Williams JW; Rakela J; Vargas HE
    Liver Transpl; 2009 Dec; 15(12):1872-81. PubMed ID: 19938138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ABO-incompatible living donor liver transplantation without graft local infusion and splenectomy.
    Lee SD; Kim SH; Kong SY; Kim YK; Lee SA; Park SJ
    HPB (Oxford); 2014 Sep; 16(9):807-13. PubMed ID: 24467804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretransplant Model for End-stage Liver Disease score has no impact on posttransplant survival in living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):396-8. PubMed ID: 22410026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult living donor liver transplantation: body mass index and MELD score of recipients are independent risk factors for hospital mortality.
    Tsui TY; Scherer MN; Schnitzbauer AA; Schlitt HJ; Obed A
    Langenbecks Arch Surg; 2009 Mar; 394(2):235-41. PubMed ID: 18512070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early postoperative renal dysfunction in the adult living donor liver transplantation.
    Lee SK; Park JB; Kim SJ; Choi GS; Kim DJ; Kwon CH; Lee SK; Joh JW
    Transplant Proc; 2007 Jun; 39(5):1517-9. PubMed ID: 17580177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
    Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
    J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation.
    Ishigami M; Honda T; Okumura A; Ishikawa T; Kobayashi M; Katano Y; Fujimoto Y; Kiuchi T; Goto H
    J Gastroenterol; 2008; 43(5):363-8. PubMed ID: 18592154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Living donor liver transplantation in adults in the MELD era in Germany--a multi-center retrospective analysis.
    Settmacher U; Götz M; Rahmel A; Bärthel E; Schlitt H; Puhl G; Broering D; Lehner F; Fischer L; Paul A; Schmidt J; Nadalin S; Obed A; Heise M
    Transpl Int; 2011 Sep; 24(9):904-11. PubMed ID: 21668530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-to-recipient weight ratio threshold adjusted to the model for end-stage liver disease score for living donor liver transplantation.
    Alim A; Erdogan Y; Yuzer Y; Tokat Y; Oezcelik A
    Liver Transpl; 2016 Dec; 22(12):1643-1648. PubMed ID: 27509534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of adult patients adopting small-for-size grafts in living donor liver transplantation: A systematic review and meta-analysis.
    Yan Y; Zheng DF; Pu JL; Wu ZJ
    Hepatobiliary Pancreat Dis Int; 2019 Jun; 18(3):206-213. PubMed ID: 30952435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Living Donation Versus Donation After Circulatory Death Liver Transplantation for Low Model for End-Stage Liver Disease Recipients.
    Kling CE; Perkins JD; Reyes JD; Montenovo MI
    Liver Transpl; 2019 Apr; 25(4):580-587. PubMed ID: 29637730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency versus elective living-donor liver transplantation: a comparison of a single center analysis.
    Takeda K; Tanaka K; Kumamoto T; Nojiri K; Mori R; Taniguchi K; Matsuyama R; Endo I
    Surg Today; 2012 May; 42(5):453-9. PubMed ID: 22116395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and Risk Factors for Liver Transplantation Using Graft-to-Recipient Weight Ratio Less Than 0.8 Graft From Living Donors: Multicentric Cohort Study.
    Kim DG; Hwang S; Kim JM; Choi Y; You YK; Choi D; Ryu JH; Kim BW; Kim DS; Cho JY; Ju MK; Kim TS; Nah YW; Lee JG; Kim MS; Joo DJ;
    Ann Surg; 2024 Jun; 279(6):1018-1024. PubMed ID: 37753651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult Living Donor Versus Deceased Donor Liver Transplant (LDLT Versus DDLT) at a Single Center: Time to Change Our Paradigm for Liver Transplant.
    Humar A; Ganesh S; Jorgensen D; Tevar A; Ganoza A; Molinari M; Hughes C
    Ann Surg; 2019 Sep; 270(3):444-451. PubMed ID: 31305283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.